Mevo Secures Major Funding to Transform Prescription Accessibility
Matrix Partner TJ Parker, co-founder and CEO of PillPack, will be joining the board.
Mevo, a groundbreaking digital prescription platform, has announced that it raised $19 million in a recent round of venture funding. This investment will significantly improve healthcare accessibility in Brazil, making it easier for people to access their prescriptions and necessary medications. The round was led by Matrix Partners, with contributions from Jefferson River Capital and other prominent investors, including Elliot Cohen, a former leader at Amazon Pharmacy. With this financial boost, Mevo intends to build on its achievements in providing streamlined services for patients.
Transforming the Healthcare Experience with Digital Solutions
Before Mevo came onto the scene, the prescription process in Brazil was largely manual and relied heavily on paper, leading to many issues, such as unfilled prescriptions and poor health outcomes. Mevo’s innovative technology allows healthcare providers to issue digital prescriptions, which patients can conveniently use at any pharmacy they prefer, including Mevo’s own pharmacy marketplace. So far, over 10 million patients have already taken advantage of Mevo’s services.
How Mevo Functions
When a customer receives a Mevo e-prescription, they can quickly finalize their purchases with just a few clicks. They’ll have their medications delivered in around 60 minutes from selected pharmacy partners or can opt to shop directly from their local pharmacy. This user-friendly process is designed to enhance medication adherence and improve the overall patient experience. Mevo has effectively partnered with numerous healthcare providers and telemedicine systems, boasting over 250 collaborations across the nation.
Future Plans for Growth and Development
Mevo has laid out distinct plans for making the most of this new funding round, which include:
- Broadening partnerships with healthcare providers.
- Further enhancing their digital prescription platform.
- Exploring a range of additional healthcare services that go beyond prescription fulfillment.
Pedro Dias, CEO and co-founder of Mevo, shared, "This investment enables us to improve our offerings and continue enhancing customer experiences. Our mission is to make healthcare access a reality for millions through their mobile devices." The progress achieved by the Mevo team positions them well to seize significant opportunities in the healthcare sector.
Community Impact and Healthcare Accessibility
Mevo addresses a pressing need within the Brazilian healthcare system: the modernization of a system that still relies heavily on traditional prescriptions. With over 150 million Brazilians depending on handwritten prescriptions, Mevo's innovations can lead to better health outcomes. The platform allows patients to easily search for and order their prescribed medications, promoting better compliance with treatment protocols.
Advantages for Healthcare Professionals and Providers
Mevo’s solutions provide crucial support to healthcare providers by greatly reducing the bureaucratic burden of paper and minimizing errors in prescription handling. A recent study indicated that over a year, physicians using Mevo reported a 33% decrease in harmful drug interactions. The integration of digital prescription data delivers real-time insights for hospitals and clinics, thus enhancing patient care and service quality.
About Mevo
Founded in 2017, Mevo's goal is to be the backbone of e-prescriptions in Brazil. The company is dedicated to improving the experiences of patients, healthcare professionals, and providers. Mevo envisions a future where healthcare management can be efficiently carried out directly from mobile devices, all while ensuring security and user-friendliness. This ongoing journey marks a significant advancement in transforming Brazil's healthcare landscape.
Frequently Asked Questions
What is Mevo?
Mevo is a prominent digital prescription platform in Brazil that allows patients to manage their prescriptions and medications through a mobile application.
How much funding did Mevo raise?
Mevo secured $19 million in its latest Series B funding round to improve its digital prescription services.
Who led the recent funding round for Mevo?
The recent funding round was spearheaded by Matrix Partners, with participation from several notable investors.
What are Mevo's goals with the funding?
Mevo plans to widen partnerships, enhance their platform, and investigate additional healthcare services with this new funding.
How does Mevo improve the prescription process?
Mevo enables healthcare providers to issue digital prescriptions, simplifying the process for patients and promoting better medication adherence.
